EDGAR Filing Documents for 0001279569-13-001348

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001279569-13-001348

Filing Date

2013-10-08

Accepted

2013-10-07 17:37:12

Documents

Period of Report

2013-10-07

Document Format Files

Seq	Description	Document	Type	Size
1		lorus6k.htm	6-K	14370
2	PRESS RELEASE DATED SEPTEMBER 12, 2013	ex991.htm	EX-99.1	10521
3	PRESS RELEASE DATED OCTOBER 1, 2013	ex992.htm	EX-99.2	10350
4	PRESS RELEASE DATED JUNE 26, 2013	ex993.htm	EX-99.3	12567
5	PRESS RELEASE DATED JULY 15, 2013	ex994.htm	EX-99.4	40665
6	PRESS RELEASE DATED APRIL 17, 2013	ex995.htm	EX-99.5	11415
7	PRESS RELEASE DATED JULY 9, 2013	ex996.htm	EX-99.6	13577
8	LOGO	logo.jpg	GRAPHIC	3211
	Complete submission text file	0001279569-13-001348.txt		119241

Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7

Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7

LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 131139879
SIC: 2836 Biological Products, (No Diagnostic Substances)